title: Response to “The Path Forward on Endocrine   Disruptors Requires Focus”.
authors.forename: Herman
authors.initials: H
authors.lastname: Autrup
authors.forename: Frank
authors.initials: F
authors.lastname: Barile
authors.forename: Bas J
authors.initials: BJ
authors.lastname: Blaauboer
authors.forename: Gisela H
authors.initials: GH
authors.lastname: Degen
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Dekant
authors.forename: Daniel
authors.initials: D
authors.lastname: Dietrich
authors.forename: Jose L
authors.initials: JL
authors.lastname: Domingo
authors.forename: Gio Batta
authors.initials: GB
authors.lastname: Gori
authors.forename: Helmuth
authors.initials: H
authors.lastname: Greim
authors.forename: Jan G
authors.initials: JG
authors.lastname: Hengstler
authors.forename: Sam
authors.initials: S
authors.lastname: Kacew
authors.forename: Hans
authors.initials: H
authors.lastname: Marquardt
authors.forename: Olavi
authors.initials: O
authors.lastname: Pelkonen
authors.forename: Kai
authors.initials: K
authors.lastname: Savolainen
authors.forename: Nico P
authors.initials: NP
authors.lastname: Vermeulen
mesh_terms: D052244:Endocrine Disruptors / Q000494:pharmacology*; D004703:Endocrine System / Q000187:drug effects*; D006801:Humans
chemical_list: D052244:Endocrine Disruptors